I migliori medici per il trattamento di Linfoma di Hodgkin - TOP-74 medici

Il Prof. MD Zafer Gulbas ha eseguito oltre 900 procedure per il linfoma di Hodgkin e ha fondato il Centro di Trapianto di Midollo Osseo presso Anadolu.

• 48 anni di esperienza in oncologia ematologica
• Formazione presso i migliori centri tra cui MD Anderson e Fred Hutchinson
• Capo dell'onco-ematologia presso l'Anadolu Medical Center
• Membro dell'American Society of Hematology

Il Dott. Bülent Karagöz è specializzato in biologia tumorale e immunoterapia, apportando oltre 20 anni di esperienza concentrata nel trattamento del linfoma di Hodgkin presso l'Anadolu Medical Center.

• Capo dell'Oncologia Medica presso il prestigioso Ospedale di Formazione GATA Haydarpaşa
• Professore presso la Facoltà di Medicina dell'Università Okan di Istanbul
• Ha pubblicato oltre 40 articoli di ricerca negli studi sul cancro
• Membro dell'Associazione Turca di Oncologia Medica

Il medico è un ostetrico e ginecologo altamente esperto con oltre 25 anni nel campo. Specializzandosi in Medicina della Riproduzione in Ostetricia e Ginecologia, il medico è esperto in trattamenti come Inseminazione Intrauterina (IUI), Procedura di Induzione dell'Ovulazione, Perforazione Ovarica e gestione delle Valvole Uretrali.<\/p>

Il medico ha completato una borsa di studio presso il Ronald O Perelman e Claudia Cohen Centre, possiede un diploma dall'Irlanda e ha conseguito un MBBS presso l'Università di Mysore, India.<\/p>

Il medico è certificato dal consiglio in Medicina Interna, Ematologia e Oncologia Medica. Il percorso professionale include una residenza presso la State University of New York a Brooklyn e una borsa di studio in Ematologia e Oncologia presso il New York Medical College, Westchester Medical Center.<\/p>

Con un forte impegno nel campo medico, il medico ha pubblicato oltre 30 articoli scientifici e ha contribuito a un capitolo di un libro di testo medico. La competenza è ulteriormente dimostrata dall'esecuzione di diverse centinaia di trapianti di cellule staminali, evidenziando l'esperienza in questo settore.<\/p>

Il medico è il capo del Dipartimento di Oncoematologia e Oncologia Pediatrica presso l'Ospedale Pediatrico Dana Dwek. Specializzandosi in trapianti di midollo osseo e sangue del cordone ombelicale per bambini, il medico ha effettuato oltre 300 trapianti. Con una forte presenza accademica, il medico ha pubblicato 50 articoli e presentato 40 relazioni in varie conferenze mediche. Il medico è membro dell'Associazione Americana di Ematologia e della Società Israeliana di Emato-oncologia Pediatrica, e ha praticato presso il City of Hope Hospital di Los Angeles e in vari centri medici in Israele.<\/p>

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Omur Gokmen Sevindik is a hematologist at Istanbul Florence Nightingale Hospital. He completed a fellowship at the Mayo Clinic, a top-ranked medical center in the US. Dr. Sevindik specializes in treating blood cancers like leukemia and lymphoma. He works at a JCI-accredited facility that treats 300,000 patients annually.

• Performs allogeneic and haploidentical stem cell transplantations.
• Authored 18 articles in international peer-reviewed journals.
• Presented research findings at over 25 international scientific conferences.
• Treats complex conditions including myeloma, aplastic anemia, and thrombocytopenia.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Bulent Eser is a hematologist at Medical Park Antalya Hospital Complex. He specializes in treating leukemia, lymphoma, and aplastic anemia. Dr. Eser is a member of the European Group for Blood and Marrow Transplantation.

• Performs allogenic bone marrow transplants from both related and unrelated donors.
• Provides CAR T-cell therapy and haploidentical stem cell transplantation.
• Treats blood cancers using biological therapy and targeted chemotherapy.
• Serves as a professor of internal medicine and hematology.

Dr. Seckin Cagirgan is a professor of hematology at Medicalpoint International Hospital in İzmir. He specializes in treating complex blood cancers like leukemia, myeloma, and lymphoma. Dr. Cagirgan rose through the ranks at Ege University from assistant professor to full professor. He works at a JCI-accredited facility known for its tumor board expertise.

• Performs allogeneic, autologous, and haploidentical stem cell transplantations.
• Treats blood disorders using photopheresis, plasmapheresis, and targeted therapies.
• Focuses on advanced treatments like chemoimmunotherapy for Hodgkin and non-Hodgkin lymphoma.
• Is an active member of the Turkish Medical Association.

Il medico è un ematologo pediatrico con specializzazione nel trapianto di midollo osseo. Con una vasta esperienza in ematologia pediatrica, il medico ha contribuito in modo significativo ai progressi nel trattamento dei disturbi del sangue nei bambini. Il medico è noto per l'implementazione di tecniche di trapianto innovative che migliorano i risultati dei pazienti e ha pubblicato numerosi articoli di ricerca su riviste mediche di primo piano.<\/p>

Dr. Toluy Ozgumus is a hematologist at Hisar Hospital Intercontinental in Istanbul. He has diagnosed and treated over 1,000 patients with bleeding and coagulation disorders. He specializes in the treatment of rare hematological cancers and bone marrow transplantation. Dr. Ozgumus works at a JCI-accredited facility recognized for excellence in hematology-oncology.

• Performs allogenic bone marrow transplants from both related and unrelated donors.
• Treats complex blood cancers including acute leukemia, multiple myeloma, and lymphomas.
• Expert in managing hematological findings related to Covid-19 infections.
• Differentiates myeloproliferative diseases from other causes of blood cell elevation.

La Professoressa Yesim Yildirim è una ricercatrice prolifica con oltre 80 pubblicazioni internazionali e si specializza nei trattamenti più recenti contro il cancro come l'immunoterapia.

• Oncologa medica da oltre 15 anni, focalizzata sul linfoma di Hodgkin e altri linfomi
• Professoressa presso l'Università di Halic, integra le ultime ricerche accademiche nella cura dei pazienti
• Possiede una certificazione ESMO, una qualificazione chiave europea in oncologia
• Ha completato una formazione avanzata in oncologia presso centri prestigiosi in Israele e nel Regno Unito
• Autrice e co-autrice di importanti manuali di oncologia

Il Prof. Kansoy ha fondato la prima unità di trapianto di midollo osseo pediatrico in Turchia e guida il programma di oncologia pediatrica presso l'Anadolu Medical Center.

• Oltre 40 anni di specializzazione in ematologia e oncologia pediatrica
• Fondatore di quattro unità di trapianto di midollo osseo pediatrico in tutta la Turchia
• Membro del consiglio della Società Turca di Ematologia Pediatrica
• Ha pubblicato ampiamente sul trapianto di cellule staminali
• Direttore di unità di trapianto accreditata EBMT

Dr. Sebnem Izmir Guner is a hematologist at Hisar Hospital Intercontinental in Istanbul. She founded and directed multiple adult bone marrow transplantation centers. Dr. Guner specializes in leukemia, lymphoma, and complex coagulation disorders. She works at a JCI-accredited facility recognized for high safety standards.

• Performs haploidentical, related, and unrelated allogenic bone marrow transplants.
• Authored over 19 articles in international peer-reviewed journals.
• Received multiple academic awards for her contributions to hematology.
• Former founder and lead physician of therapeutic apheresis units.

Dr. Oguzhan Babacan is a pediatric hematologist-oncologist at Hisar Hospital Intercontinental in Istanbul. He specializes in bone marrow transplantation for children with leukemia and lymphoma. Dr. Babacan has performed allogeneic, autologous, and haploidentical stem cell transplants for 13 years. He treats rare blood disorders and solid tumors in pediatric patients.

• Performs complex bone marrow transplants for leukemia and lymphoma cases.
• Treats childhood blood disorders like thalassemia, hemophilia, and aplastic anemia.
• Expertise in pediatric oncology, including neuroblastoma and Ewing's sarcoma.
• Works at Hisar Hospital, a JCI-accredited facility in Turkey.

Dr. Francesc Cobo Valien is a leading oncohematologist at the Teknon Oncology Institute in Barcelona. He specializes in treating complex blood cancers, including leukemia and lymphoma. Dr. Cobo Valien earned his medical degree and doctorate from the University of Barcelona. He serves patients at Centro Médico Teknon, a JCI-accredited facility.

• Treats acute and chronic leukemia, Hodgkin's lymphoma, and multiple myeloma.
• Performs bone marrow transplants and biological therapy for hematologic malignancies.
• Recipient of the Spanish Hematology Association award for medical reporting.
• Heads research projects supported by the Catalan Society of Hematology.

Dr. Deniz Gören is a hematologist at Memorial Şişli Hospital in Istanbul. She specializes in treating blood cancers and complex bone marrow disorders. Dr. Gören represents the European Society for Blood and Marrow Transplantation. She completed selective medical training at Harvard University Faculty of Medicine.

• Treats leukemia, lymphoma, myeloma, and aplastic anemia.
• Completed a specialist masterclass in lymphoma at the Turkish Academy of Blood Science.
• Practices at JCI-accredited Memorial Şişli, which reports a 90% organ transplant success rate.
• Member of the Turkish Academy of Blood Science and the EBMT.